Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11382158 | 2011-05-19 | ||
EP12275024 | 2012-03-09 | ||
PCT/GB2012/051134WO2012156756A2 (en) | 2011-05-19 | 2012-05-18 | New compounds |
Publication Number | Publication Date |
---|---|
SG11201400681UAtrue SG11201400681UA (en) | 2014-08-28 |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201400681UASG11201400681UA (en) | 2011-05-19 | 2012-05-18 | Macrocyclic compounds as protein kinase inhibitors |
Country | Link |
---|---|
US (2) | US9284334B2 (en) |
EP (1) | EP2710018B8 (en) |
JP (1) | JP5997763B2 (en) |
KR (1) | KR101953210B1 (en) |
CN (1) | CN103748099B (en) |
AU (1) | AU2012257513B2 (en) |
BR (1) | BR112013029711B1 (en) |
CA (1) | CA2872979C (en) |
DK (1) | DK2710018T3 (en) |
ES (1) | ES2907071T3 (en) |
HR (1) | HRP20220319T1 (en) |
MX (1) | MX349366B (en) |
NZ (1) | NZ618157A (en) |
PH (1) | PH12013502400A1 (en) |
PL (1) | PL2710018T3 (en) |
PT (1) | PT2710018T (en) |
RU (1) | RU2598840C2 (en) |
SG (1) | SG11201400681UA (en) |
WO (1) | WO2012156756A2 (en) |
ZA (1) | ZA201309128B (en) |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9428845B1 (en) | 2010-12-28 | 2016-08-30 | Warp Drive Bio, Inc. | Identifying new therapeutic agents |
PH12013502400A1 (en) | 2011-05-19 | 2014-01-20 | Fundacion Del Sector Publico Estatal Centro Nac De Investigaciones Oncologicas Carlos Iii F S P Cnio | Macrocyclic compounds as protein kinase inhibitors |
RU2622104C2 (en)* | 2011-09-30 | 2017-06-13 | Онкодизайн С.А. | Macrocyclic lrrk2 kinase inhibitors |
CN103788071A (en)* | 2012-11-01 | 2014-05-14 | 中国人民解放军第二军医大学 | N-(5-(quinolyl-6-yl) pyridyl-3-yl)benzsulfamide derivatives, and preparation method and treatment use thereof |
TWI574962B (en) | 2012-11-14 | 2017-03-21 | 加拓科學公司 | Heteroaromatic compounds as pi3 kinase modulators and methods of use |
EP2943485B1 (en) | 2013-01-14 | 2017-09-20 | Incyte Holdings Corporation | Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors |
AU2014207691B2 (en) | 2013-01-15 | 2018-08-30 | Incyte Holdings Corporation | Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors |
AU2014219256B2 (en) | 2013-02-21 | 2017-02-16 | Sunshine Lake Pharma Co., Ltd. | Heteroaromatic compounds as PI3 kinase modulators |
EP2970297A1 (en)* | 2013-03-14 | 2016-01-20 | Bristol-Myers Squibb Company | Inhibitors of human immunodeficiency virus replication |
CA2914414A1 (en)* | 2013-06-06 | 2014-12-11 | Glaxosmithkline Intellectual Property (No.2) Limited | Enhancer of zeste homolog 2 inhibitors |
CN104341299B (en)* | 2013-07-29 | 2016-08-24 | 漳州金富顺生物科技有限公司 | A kind of esterification of deodorised fat acid |
EA201690458A1 (en) | 2013-08-23 | 2016-07-29 | Инсайт Корпорейшн | FURO- AND THYENOPYRIDINCARBOXAMIDES USED AS PIM-KINASE INHIBITORS |
CN104418853B (en)* | 2013-08-28 | 2016-09-07 | 北大方正集团有限公司 | Substituted naphthyridines-2-ketonic compound, preparation method, purposes and pharmaceutical composition |
AR097543A1 (en)* | 2013-09-06 | 2016-03-23 | Lexicon Pharmaceuticals Inc | COMPOUNDS BASED ON IMIDAZO [1,2-b] PIRIDAZINE, COMPOSITIONS THAT INCLUDE THEM AND THEIR METHODS OF USE |
TW201542550A (en)* | 2013-09-06 | 2015-11-16 | Lexicon Pharmaceuticals Inc | Pyrazolo[1,5-a]pyrimidinyl compound, composition comprising the same, and method of using the same |
JP6542236B2 (en)* | 2014-01-09 | 2019-07-10 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | Organic compound |
US9822124B2 (en) | 2014-07-14 | 2017-11-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors |
US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
CN105693744B (en)* | 2014-11-27 | 2018-06-19 | 北大方正集团有限公司 | A kind of substituted Thienopyrimidine compound and preparation method thereof |
EP3247378B8 (en) | 2015-01-09 | 2023-08-23 | Revolution Medicines, Inc. | Macrocyclic compounds that participate in cooperative binding and medical uses thereof |
US9540347B2 (en) | 2015-05-29 | 2017-01-10 | Incyte Corporation | Pyridineamine compounds useful as Pim kinase inhibitors |
CN104961725B (en)* | 2015-06-18 | 2017-04-19 | 浙江大学 | 4-alpha, beta-unsaturated carboxamidoquinoline compounds and preparation and application |
CN106467545B (en)* | 2015-08-20 | 2018-10-16 | 北大方正集团有限公司 | A kind of Thienopyrimidine compound |
TWI734699B (en) | 2015-09-09 | 2021-08-01 | 美商英塞特公司 | Salts of a pim kinase inhibitor |
WO2017059207A1 (en) | 2015-10-01 | 2017-04-06 | Warp Drive Bio, Inc. | Methods and reagents for analyzing protein-protein interfaces |
US9920032B2 (en) | 2015-10-02 | 2018-03-20 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
CN109311868B (en) | 2015-12-22 | 2022-04-01 | 尚医治疗有限责任公司 | Compounds for the treatment of cancer and inflammatory diseases |
WO2017156350A1 (en) | 2016-03-09 | 2017-09-14 | K-Gen, Inc. | Methods of cancer treatment |
AR108301A1 (en)* | 2016-04-22 | 2018-08-08 | Astrazeneca Ab | MCL-1 INHIBITORS AND SAME USE METHODS |
US10947225B2 (en) | 2016-05-11 | 2021-03-16 | Emory University | Phosphotidylinositol 3-kinase inhibitors |
ES3002745T3 (en)* | 2016-07-06 | 2025-03-07 | Univ Michigan Regents | Multifunctional inhibitors of mek/pi3k and mtor/mek/pi3k biological pathways and therapeutic methods using the same |
WO2018013430A2 (en) | 2016-07-12 | 2018-01-18 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus infection |
MX2019001125A (en)* | 2016-07-28 | 2019-06-12 | Tp Therapeutics Inc | Macrocycle kinase inhibitors. |
CN116651422A (en) | 2017-03-16 | 2023-08-29 | 沃特世科技公司 | Chromatographic composition |
EP3642209B1 (en) | 2017-06-21 | 2023-11-29 | Shy Therapeutics LLC | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
JP2020531457A (en)* | 2017-08-15 | 2020-11-05 | アッヴィ・インコーポレイテッド | Macrocyclic MCL-1 inhibitor and method of use |
US10596161B2 (en) | 2017-12-08 | 2020-03-24 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
UA128407C2 (en)* | 2018-08-24 | 2024-07-03 | Байєр Акцієнгезелльшафт | Method for preparing 2-[(3r)-3-methylmorpholin-4-yl]-4-[1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-5-yl)-1,7-naphthyridine |
EP3878854A4 (en) | 2018-11-09 | 2022-08-10 | Shandong Xuanzhu Pharma Co., Ltd. | MACROCYCLIC TYROSINE KINASE INHIBITOR AND ITS APPLICATION |
TW202039509A (en)* | 2018-12-21 | 2020-11-01 | 美商銳新醫藥公司 | Compounds that participate in cooperative binding and uses thereof |
CN113874015B (en) | 2018-12-21 | 2024-05-24 | 细胞基因公司 | Thienopyridine inhibitors of RIPK2 |
CN109988165B (en)* | 2018-12-24 | 2022-10-25 | 华东师范大学 | Aromatic heterocyclic compounds as PI3K/mTOR kinase regulators and their preparation methods and applications |
MX2022005359A (en) | 2019-11-04 | 2022-06-02 | Revolution Medicines Inc | Ras inhibitors. |
PE20221277A1 (en) | 2019-11-04 | 2022-09-05 | Revolution Medicines Inc | RAS INHIBITORS |
BR112022008535A2 (en) | 2019-11-04 | 2022-08-09 | Revolution Medicines Inc | COMPOUND, PHARMACEUTICAL COMPOSITION, METHODS TO TREAT CANCER AND A RAS PROTEIN DISORDER |
EP4132921A4 (en)* | 2020-04-09 | 2024-03-27 | Purdue Research Foundation | PI3 KINASE INHIBITORS AND USES THEREOF |
US20230183265A1 (en)* | 2020-05-08 | 2023-06-15 | Shandong Xuanzhu Pharma Co., Ltd. | Crystal Form of Macrocyclic Tyrosine Kinase Inhibitor and Preparation Method therefor |
CN113620976B (en)* | 2020-05-09 | 2023-09-26 | 中国医学科学院药物研究所 | Thiazolopyrimidine compound, preparation method, application and pharmaceutical composition thereof |
EP4167982A4 (en) | 2020-06-22 | 2024-08-07 | PMV Pharmaceuticals, Inc. | METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION |
CN116457358A (en) | 2020-09-15 | 2023-07-18 | 锐新医药公司 | Indole derivatives as RAS inhibitors for the treatment of cancer |
EP4334325A1 (en) | 2021-05-05 | 2024-03-13 | Revolution Medicines, Inc. | Ras inhibitors for the treatment of cancer |
CN113416181B (en)* | 2021-08-02 | 2022-05-03 | 四川大学 | Quinazoline derivatives and their uses |
AR127308A1 (en) | 2021-10-08 | 2024-01-10 | Revolution Medicines Inc | RAS INHIBITORS |
CN116262758B (en)* | 2021-12-15 | 2025-02-28 | 上海博悦生物科技有限公司 | 7-Methylthiazolo[5,4-d]pyrimidine compounds, preparation methods and uses thereof |
WO2025061125A1 (en)* | 2023-09-22 | 2025-03-27 | 四川汇宇制药股份有限公司 | Macrocyclic compound, preparation method therefor and use thereof |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1147478A (en) | 1914-11-03 | 1915-07-20 | Charles H Barker | War-maneuvering game. |
US5583024A (en) | 1985-12-02 | 1996-12-10 | The Regents Of The University Of California | Recombinant expression of Coleoptera luciferase |
FR2601675B1 (en) | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US5750561A (en) | 1991-07-08 | 1998-05-12 | Rhone-Poulenc Rorer, S.A. | Compositions containing taxane derivatives |
US5698582A (en) | 1991-07-08 | 1997-12-16 | Rhone-Poulenc Rorer S.A. | Compositions containing taxane derivatives |
US5714512A (en) | 1991-07-08 | 1998-02-03 | Rhone-Poulenc Rorer, S.A. | Compositions containing taxane derivatives |
FR2698543B1 (en) | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | New taxoid-based compositions. |
JPH08336393A (en) | 1995-04-13 | 1996-12-24 | Mitsubishi Chem Corp | Process for producing optically active γ-substituted-β-hydroxybutyric acid ester |
CZ144798A3 (en) | 1995-11-14 | 1998-10-14 | The Du Pont Merck Pharmaceutical Company | Novel macrocyclic compounds functioning as metalloproteinase inhibitors |
US6602677B1 (en) | 1997-09-19 | 2003-08-05 | Promega Corporation | Thermostable luciferases and methods of production |
GB9800569D0 (en) | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
ATE377597T1 (en) | 1999-07-09 | 2007-11-15 | Glaxo Group Ltd | ANILINOQUINAZOLINES AS PROTEIN TYROSINE KINASE INHIBITORS |
US6933299B1 (en) | 1999-07-09 | 2005-08-23 | Smithkline Beecham Corporation | Anilinoquinazolines as protein tyrosine kinase inhibitors |
CZ300945B6 (en) | 2000-06-30 | 2009-09-23 | Glaxo Group Limited | Process for preparing 5-(6-quinazolinyl)-furan-2-carbaldehydes |
PT1301472E (en) | 2000-07-19 | 2014-05-15 | Warner Lambert Co | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
EP1353693B1 (en) | 2001-01-16 | 2005-03-16 | Glaxo Group Limited | Pharmaceutical combination containing a 4-quinazolineamine and paclitaxel, carboplatin or vinorelbine for the treatment of cancer |
IL149462A0 (en) | 2001-05-09 | 2002-11-10 | Warner Lambert Co | Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor |
DE10239042A1 (en)* | 2002-08-21 | 2004-03-04 | Schering Ag | New fused macrocyclic pyrimidine derivatives, useful as e.g. cyclin-dependent kinase inhibitors for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections |
JP2006508974A (en) | 2002-11-15 | 2006-03-16 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | Combination chemotherapy comprising MEK inhibitor and capecitabine (CAPECITABINE) for treating cancer |
MXPA06004363A (en) | 2003-10-21 | 2006-06-14 | Warner Lambert Co | Polymorphic form of n-[(r)-2, 3-dihydroxy -propoxy]-3, 4-difluoro-2 -(2-fluoro-4 -iodophenylamino) -benzamide. |
EA025871B9 (en) | 2005-10-07 | 2017-08-31 | Экселиксис, Инк. | Mek inhibitors and methods of using the same |
WO2008049902A2 (en) | 2006-10-27 | 2008-05-02 | Janssen Pharmaceutica Nv | Macrocyclic quinazoline derivatives as vegfr3 inhibitors |
WO2008150827A1 (en) | 2007-05-29 | 2008-12-11 | Smithkline Beecham Corporation | Naphthyridine, derivatives as p13 kinase inhibitors |
CN101878219B (en) | 2007-09-27 | 2014-04-02 | 西班牙国家癌症研究中心 | Imidazolothiadiazoles for use as protein kinase inhibitors |
EP2211615A4 (en) | 2007-10-22 | 2010-10-13 | Glaxosmithkline Llc | Pyridosulfonamide derivatives as pi3 kinase inhibitors |
ES2668834T3 (en) | 2008-09-08 | 2018-05-22 | Merck Serono Sa | Macrocyclic pyrimidines as protein kinase inhibitors |
US8765727B2 (en) | 2009-01-23 | 2014-07-01 | Incyte Corporation | Macrocyclic compounds and their use as kinase inhibitors |
CA2753285A1 (en) | 2009-03-12 | 2010-09-16 | Genentech, Inc. | Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies |
MX2011009796A (en)* | 2009-03-20 | 2011-12-14 | Amgen Inc | Inhibitors of pi3 kinase. |
WO2010112874A1 (en) | 2009-04-02 | 2010-10-07 | Centro Nacional De Investigaciones Oncologicas (Cnio) | Imidazo [2, 1-b] [ 1, 3, 4 ] thiadiazole derivatives |
AU2010284254B2 (en) | 2009-08-17 | 2015-09-17 | Intellikine, Llc | Heterocyclic compounds and uses thereof |
PH12013502400A1 (en) | 2011-05-19 | 2014-01-20 | Fundacion Del Sector Publico Estatal Centro Nac De Investigaciones Oncologicas Carlos Iii F S P Cnio | Macrocyclic compounds as protein kinase inhibitors |
WO2013001310A1 (en) | 2011-06-30 | 2013-01-03 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Macrocyclic compounds and their use as cdk8 inhibitors |
Publication number | Publication date |
---|---|
BR112013029711A2 (en) | 2017-01-24 |
DK2710018T3 (en) | 2022-03-21 |
RU2598840C2 (en) | 2016-09-27 |
KR101953210B1 (en) | 2019-02-28 |
US20140256717A1 (en) | 2014-09-11 |
ES2907071T3 (en) | 2022-04-21 |
JP5997763B2 (en) | 2016-09-28 |
NZ618157A (en) | 2015-07-31 |
CA2872979C (en) | 2020-02-18 |
CN103748099A (en) | 2014-04-23 |
BR112013029711B1 (en) | 2020-05-12 |
JP2014515346A (en) | 2014-06-30 |
RU2013156361A (en) | 2015-06-27 |
HRP20220319T1 (en) | 2022-05-13 |
ZA201309128B (en) | 2014-08-27 |
EP2710018B8 (en) | 2022-02-23 |
MX349366B (en) | 2017-07-26 |
US20160296528A1 (en) | 2016-10-13 |
PT2710018T (en) | 2022-03-01 |
EP2710018B1 (en) | 2021-12-29 |
CA2872979A1 (en) | 2012-11-22 |
US9284334B2 (en) | 2016-03-15 |
WO2012156756A3 (en) | 2013-01-10 |
KR20140043092A (en) | 2014-04-08 |
MX2013013462A (en) | 2014-02-27 |
AU2012257513B2 (en) | 2017-05-11 |
CN103748099B (en) | 2016-08-17 |
AU2012257513A1 (en) | 2013-12-12 |
PH12013502400A1 (en) | 2014-01-20 |
US9808466B2 (en) | 2017-11-07 |
EP2710018A2 (en) | 2014-03-26 |
PL2710018T3 (en) | 2022-04-04 |
WO2012156756A2 (en) | 2012-11-22 |
Publication | Publication Date | Title |
---|---|---|
ZA201309128B (en) | Macrocyclic compounds as protein kinase inhibitors | |
ZA201402164B (en) | Protein kinase inhibitors | |
EP2694517A4 (en) | Protein kinase inhibitors | |
AP2013007252A0 (en) | Heterocyclic compounds as kinase inhibitors | |
ZA201404156B (en) | Kinase inhibitors | |
HUE048834T2 (en) | Kinase inhibitors | |
ZA201402561B (en) | Benzonitrile derivatives as kinase inhibitors | |
IL228103A0 (en) | Amino-quinolines as kinase inhibitors | |
PT3409278T (en) | Heterocyclic protein kinase inhibitors | |
IL229028A0 (en) | Kinase inhibitors | |
ZA201306855B (en) | Protein kinase inhibitors | |
EP2685992A4 (en) | Amino-quinolines as kinase inhibitors | |
ZA201306025B (en) | Phosphorus containing compounds as protein kinase inhibitors | |
ZA201404157B (en) | Kinase inhibitors |